ArticleNeuro-oncology advances

High-dose methotrexate-based regimens with or without vincristine for the treatment of primary central nervous system lymphoma.

Tracelyn Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.